Literature DB >> 26788131

The optimal management of headaches in children and adolescents.

Joanne Kacperski1, Marielle A Kabbouche2, Hope L O'Brien2, Jessica L Weberding3.   

Abstract

The recognition of the diagnosis of migraine in children is increasing. Early and aggressive treatment of migraine in this population with the use of over-the-counter medications has proven effective. The off-label use of many migraine-specific medications is often accepted in the absence of sufficient evidenced-based trials. Mild to severe cases of migraine should be treated with nonsteroidal anti-inflammatory drugs, with triptans used in moderate to severe headaches unresponsive to over-the-counter therapy. Rescue medication including dihydroergotamine [DHE] should be used for status migrainosus, preferably in the hospital setting. Antiemetics that have antidopaminergic properties can be helpful in patients with associated symptoms of nausea and vomiting through their action on central migraine generation. Furthermore, patients and families should be educated on nonpharmacologic management such as lifestyle modification and avoidance of triggers that can prevent episodic migraine.

Entities:  

Keywords:  headache; migraine; pediatric headache

Year:  2016        PMID: 26788131      PMCID: PMC4710107          DOI: 10.1177/1756285615616586

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  94 in total

Review 1.  Nutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations.

Authors:  Serena L Orr; Sunita Venkateswaran
Journal:  Cephalalgia       Date:  2014-01-17       Impact factor: 6.292

2.  Evaluation and management of children and adolescents presenting with an acute setting.

Authors:  Marielle A Kabbouche; Catalina Cleves
Journal:  Semin Pediatr Neurol       Date:  2010-06       Impact factor: 1.636

Review 3.  The evaluation of headaches in children and adolescents.

Authors:  A D Rothner
Journal:  Semin Pediatr Neurol       Date:  1995-06       Impact factor: 1.636

Review 4.  Practice parameter: pharmacological treatment of migraine headache in children and adolescents: report of the American Academy of Neurology Quality Standards Subcommittee and the Practice Committee of the Child Neurology Society.

Authors:  D Lewis; S Ashwal; A Hershey; D Hirtz; M Yonker; S Silberstein
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

Review 5.  Current approaches to the diagnosis and management of paediatric migraine.

Authors:  Andrew D Hershey
Journal:  Lancet Neurol       Date:  2010-02       Impact factor: 44.182

6.  A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.

Authors:  Morris Maizels; Andrew Blumenfeld; Raoul Burchette
Journal:  Headache       Date:  2004-10       Impact factor: 5.887

7.  A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.

Authors:  Frederick G Freitag; S D Collins; H A Carlson; J Goldstein; J Saper; S Silberstein; N Mathew; P K Winner; R Deaton; K Sommerville
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

8.  Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age.

Authors:  Donald Lewis; Paul Winner; Joel Saper; Seth Ness; Elena Polverejan; Steven Wang; Caryn L Kurland; Jeff Nye; Eric Yuen; Marielle Eerdekens; Lisa Ford
Journal:  Pediatrics       Date:  2009-03       Impact factor: 7.124

9.  Intravenous magnesium as acute treatment for headaches: a pediatric case series.

Authors:  Emily Gertsch; Sheila Loharuka; Kristine Wolter-Warmerdam; Suhong Tong; Allison Kempe; Sita Kedia
Journal:  J Emerg Med       Date:  2013-10-29       Impact factor: 1.484

10.  Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache.

Authors:  M Coppola; D M Yealy; R A Leibold
Journal:  Ann Emerg Med       Date:  1995-11       Impact factor: 5.721

View more
  6 in total

1.  Pediatric Headache in Primary Care and Emergency Departments: Consensus with RAND/UCLA Method.

Authors:  Giovanni Prezioso; Agnese Suppiej; Valentina Alberghini; Patrizia Bergonzini; Maria Elena Capra; Ilaria Corsini; Alessandro De Fanti; Elisa Fiumana; Martina Fornaro; Lucia Marangio; Paolo Ricciardelli; Laura Serra; Duccio Maria Cordelli; Susanna Esposito
Journal:  Life (Basel)       Date:  2022-01-19

2.  A Comparative Study on the Efficacy of Coenzyme Q10 and Amitriptyline in the Prophylactic Treatment of Migraine Headaches in Children: A Randomized Controlled Trial.

Authors:  Omid Yaghini; Neda Hoseini; Mohammad Reza Ghazavi; Vahid Mansouri; Jafar Nasiri; Toktam Moosavian; Mohammad Mehdi Salehi
Journal:  Adv Biomed Res       Date:  2022-05-30

Review 3.  Drug Treatment of Epilepsy Neuropsychiatric Comorbidities in Children.

Authors:  Gregory L Holmes
Journal:  Paediatr Drugs       Date:  2020-11-24       Impact factor: 3.022

4.  A Possible Pathogenic Linkage Among Headache, Migraine, and Nocturnal Enuresis in Children.

Authors:  Pietro Ferrara; Livia Dell'Aquila; Giacomo Perrone; Giulia Spina; Francesco Miconi; Valentina Rapaccini; Ester Del Vescovo; Vincenzo Di Lazzaro; Alberto Verrotti
Journal:  Int Neurourol J       Date:  2016-12-26       Impact factor: 2.835

Review 5.  Migraine and Mood in Children.

Authors:  Parisa Gazerani
Journal:  Behav Sci (Basel)       Date:  2021-04-14

Review 6.  Management of Chronic Migraine in Children and Adolescents: Where are We in 2022?

Authors:  Robert C Gibler; Kaelynn E Knestrick; Brooke L Reidy; Daniel N Lax; Scott W Powers
Journal:  Pediatric Health Med Ther       Date:  2022-09-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.